Insider Transactions Reported by 13 Insiders of Protagonist Therapeutics, Inc

Symbol
PTGX on Nasdaq
Location
Newark, CA

Insiders trading volume in the past year

Protagonist Therapeutics, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PATEL DINESH V PH D President and CEO, Director $39,095,610 -$3,655,184 -8.5% 21 Nov 2025
ARTURO MOLINA Chief Medical Officer $6,881,628 -$3,056,147 -31% 17 Nov 2025
David Y. Liu Chief R&D Strategy Officer $4,127,742 16 Nov 2022
Suneel Gupta Chief Development Officer $3,254,660 25 Nov 2024
Asif Ali Chief Financial Officer $2,808,990 -$1,543,329 -35% 22 Apr 2025
Bryan Giraudo Director $1,036,918 02 Jan 2025
Donald A. Kalkofen Chief Financial Officer $456,172 15 Feb 2022
William Waddill Director $450,465 -$1,690,480 -79% 10 Oct 2025
Lewis T. Williams Director $229,978 02 Jan 2025
Sarah A. O'Dowd Director $229,978 02 Jan 2025
HAROLD E. SELICK Director $50,867 28 Apr 2025
Daniel N. Swisher JR Director 26 Oct 2023
Sarah B. Noonberg Director 16 Jan 2023

Recent Insider Transactions by Companies or Individuals for Protagonist Therapeutics, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.